-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-153-section-7b-appendix-8.pdf
June 30, 2009 - Chronic Disease Healthy
Metric N Metric N
IL
0.9667
(0.9663,0.9671)
488719
0.9147
(0.9143,0.9151
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-final-es-cs061721.pdf
December 01, 2020 - Administration for
Community Living, Assistant Secretary for Planning and Evaluation, Centers for Disease … Healthcare System infrastructure
Overview of Disease Burden in the United States
Overview of U.S. … Blacks
Changes in Disparities for Blacks
Treatment for Depression
New HIV Cases
End Stage Renal Disease … and Alaska Natives
Changes in Disparities for American Indians and Alaska Natives
End Stage Renal Disease … Deaths
Changes in Quality of Care for Hispanics
Changes in Disparities for Hispanics
End Stage Renal Disease
-
www.monahrq.ahrq.gov/news/newsletters/e-newsletter/881.html
September 01, 2023 - September 19, 2023
AHRQ Stats: Race-Related Differences in Heart Disease Treatment
In 2020, 9.8 percent … of non-Hispanic White adults received heart disease treatment compared with 6.9 percent of non-Hispanic … Source: AHRQ Medical Expenditure Panel Survey Statistical Brief #550, Healthcare Expenditures for Heart Disease
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/tpc/tpc-profile-donahue.pdf
April 01, 2015 - provided practices with monthly practice change and leadership
ratings to track implementation and use of disease … (KDIS) to document and measure the extent
of implementation in four key areas of practice change: disease
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - addressing childhood obesity may have implications for the subsequent development
of cardiovascular diseases … The Global Burden of Disease study of 2010
identified depression as a leading cause of disease burden … Centers for Disease Control and Prevention (CDC). … Disability-adjusted life years (DALYs) for 291 diseases and
injuries in 21 regions, 1990-2010: A systematic … Depression and the risk for cardiovascular
diseases: Systematic review and meta-analysis.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - addressing childhood obesity may have implications for the subsequent development
of cardiovascular diseases … The Global Burden of Disease Study of
2010 identified depression as a leading cause of disease burden … Centers for Disease Control and Prevention (CDC). … Disability-adjusted life years (DALYs) for 291 diseases and
injuries in 21 regions, 1990-2010: A systematic … Depression and the risk for cardiovascular
diseases: Systematic review and meta-analysis.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/state-key-drive-diagram.pdf
January 29, 2021 - plan baseline performance
rates and processes aimed at improving
care for children with sickle cell disease
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fecc-figure-1-tables-1-5.pdf
January 01, 2011 - (N=24 RCTs)
Cochrane review to assess the
effects of IHCAs for people with
chronic disease
↑
11 … Intervention
patients were matched to 2 patients
from control clinics on age, comorbid
score, sex, specific diseases … Katon,50 2001 386 adults with major Disease management: ↑ ↑/
RCT
depression, currently
controlled … Unutzer,49 2002 1801 adults >59 years old
with major depression or
Disease management:
Intervention … Interactive Health Communication Applications for people with chronic disease.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/nursing-home/materials/vaccine-conversation-guide.pdf
May 20, 2021 - “Vaccination is a collective
action to prevent the
spread of diseases.”
-
www.monahrq.ahrq.gov/downloads/pub/advances/vol1/Schillinger.pdf
January 01, 2004 - documented the prevalence and consequences of
patient non-adherence (e.g., pill-taking) in the chronic disease … discordance between patient and
provider,9, 12, 13 or the contribution of regimen discordance to chronic disease … We
excluded patients with any International Classification of Diseases (ICD)-9
diagnosis of psychotic … Most patients were taking warfarin for atrial fibrillation (62 percent)
and/or valvular heart disease … had similar findings.24
Given the prevalence of chronic diseases,52 the challenge of managing
multiple
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-section-6-tables-4-6.pdf
January 23, 2019 - Availability of maternal fetal medicine specialist or cardiologist for
pregnant women with cardiac disease
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-199-section-8-a-ehr-data-feasibility-tool.pdf
November 20, 2017 - or the notes field N/A
4 Appropriateness of Red Cell
Transfusions
Patients with cyanotic heart
disease … May be identified by: SNOMEDCT 12770006
(Cyanotic congenital heart disease)
N/A
4 Appropriateness … oxygenation [ECMO] )
N/A
4 Appropriateness of Red Cell
Transfusions
Patients with sickle cell
disease … Identified by ICD-9-CM code 282.6 (Sickle-cell
disease)
or ICD-9-CM 282.60 (Sickle-cell disease,
-
www.monahrq.ahrq.gov/hai/tools/clabsi-cauti-icu/index.html
March 01, 2023 - Centers for Disease Control and Prevention. 2018. … Centers for Disease Control and Prevention. 2019.
-
www.monahrq.ahrq.gov/news/newsroom/case-studies/202203.html
April 01, 2022 - Other previous topics based on AHRQ research include depression, diabetes, kidney disease, pressure ulcers … Evidence Report
Topic(s):
COVID-19,
Depression,
Diabetes,
Kidney Disease
-
www.monahrq.ahrq.gov/patient-safety/settings/ambulatory/improve/six-building-blocks-about.html
November 01, 2021 - Tools
Toolkit for Engaging Patients To Improve Diagnostic Safety
End-Stage Renal Disease … State Department of Health subcontract (HED23124) of Cooperative U17CE002734, from the Centers for Disease
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
August 22, 2018 - would like to understand how your practice uses registries and clinical guidelines for cardiovascular disease … identify services due, gaps in care, or track
progress: (Check all that apply)
Ischemic vascular disease … determined core item
Please identify how your practice uses clinical guidelines for cardiovascular disease … prevention (for example, use of aspirin or antithrombotics for
those with ischemic vascular disease … Collaborative…………………………………………demo_prog_mh_collab.. 1 = Yes 2 = No
Million Hearts: Cardiovascular Disease
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-section-8-data-feasibility-tool-1.pdf
November 28, 2017 - or the notes field N/A
4 Appropriateness of Red Cell
Transfusions
Patients with cyanotic heart
disease … May be identified by: SNOMEDCT 12770006
(Cyanotic congenital heart disease)
N/A
4 Appropriateness … oxygenation [ECMO] )
N/A
4 Appropriateness of Red Cell
Transfusions
Patients with sickle cell
disease … Identified by ICD-9-CM code 282.6 (Sickle-cell
disease)
or ICD-9-CM 282.60 (Sickle-cell disease,
-
www.monahrq.ahrq.gov/es/nursing-home/resources/search.html?page=3
January 01, 2022 - COVID-19 Booster Shot Fact Sheet The Centers for Disease Control and Prevention (CDC) provides answers … Nursing Home Data This interactive website includes data reported by nursing homes to the Centers for Disease … COVID-19 Vaccine Access in Long-term Care Settings This Centers for Disease Control and Prevention (CDC
-
www.monahrq.ahrq.gov/es/nursing-home/resources/search.html?page=6
January 01, 2022 - Stories These stories from long term care facilities focus on key takeaways from implementing Centers for Disease … Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease … The Centers for Disease Control and Prevention (CDC) has updated select healthcare infection prevention
-
www.monahrq.ahrq.gov/funding/training-grants/grants/active/kawards/Kawdsumolom.html
October 01, 2014 - Improve the implementation of evidence-based guidelines for secondary prevention of coronary heart disease … a focus on research to improve the quality of care for blacks and low income populations with heart disease